FEATURED COMPANIES
- Abbott Vascular Inc
- Biosten, LLC
- DISA Vascular (Pty) Ltd
- Medinol Ltd
- Nexeon MedSystems Inc
- Tepha Inc
- MORE
Summary
The publisher's Medical Devices sector report, “Coronary Stents - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Coronary Stents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
A stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a disease-induced localized flow constriction.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
The report enables you to -
The publisher's Medical Devices sector report, “Coronary Stents - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Coronary Stents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
A stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a disease-induced localized flow constriction.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Coronary Stents under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Coronary Stents and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Coronary Stents under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Vascular Inc
- Biosten, LLC
- DISA Vascular (Pty) Ltd
- Medinol Ltd
- Nexeon MedSystems Inc
- Tepha Inc
- MORE
1 Table of Contents
2 Introduction
2.1 Coronary Stents Overview
3 Products under Development
3.1 Coronary Stents-Pipeline Products by Stage of Development
3.2 Coronary Stents-Pipeline Products by Segment
3.3 Coronary Stents-Pipeline Products by Territory
3.4 Coronary Stents-Pipeline Products by Regulatory Path
3.5 Coronary Stents-Pipeline Products by Estimated Approval Date
3.6 Coronary Stents-Ongoing Clinical Trials
4 Coronary Stents-Pipeline Products under Development by Companies
4.1 Coronary Stents Companies-Pipeline Products by Stage of Development
4.2 Coronary Stents-Pipeline Products by Stage of Development
5 Coronary Stents Companies and Product Overview
6 Coronary Stents-Recent Developments
7 Appendix
List of Tables
Table 1: Coronary Stents-Pipeline Products by Stage of Development
Table 2: Coronary Stents-Pipeline Products by Segment
Table 3: Coronary Stents-Pipeline Products by Territory
Table 4: Coronary Stents-Pipeline Products by Regulatory Path
Table 5: Coronary Stents-Pipeline Products by Estimated Approval Date
Table 6: Coronary Stents-Ongoing Clinical Trials
Table 7: Coronary Stents Companies-Pipeline Products by Stage of Development
Table 8: Coronary Stents-Pipeline Products by Stage of Development
Table 9: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Second Generation Bioresorbable Vascular Scaffold-Product Status
Table 11: Second Generation Bioresorbable Vascular Scaffold-Product Description
Table 12: Xience SBA Everolimus Eluting Coronary Stent System-Product Status
Table 13: Xience SBA Everolimus Eluting Coronary Stent System-Product Description
Table 14: XIENCE Thin man DES-Product Status
Table 15: XIENCE Thin man DES-Product Description
Table 16: ZoMaxx Drug Eluting Coronary Stent System-Product Status
Table 17: ZoMaxx Drug Eluting Coronary Stent System-Product Description
Table 18: Abbott Vascular Inc-Ongoing Clinical Trials Overview
Table 19: Xience SBA Everolimus Eluting Coronary Stent System-A Multi-center, Randomized, Controlled Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries: CRYSTAL Study
Table 20: Xience SBA Everolimus Eluting Coronary Stent System-A Prospective Global Randomized Trial Assessing the Safety and Efficacy of the BuMA Supreme Biodegradable Drug Coated Coronary Stent System for Coronary Revascularization in Patients with Stable Coronary Artery Disease or Non-ST Segment Elevation Acute Coronary Syndromes
Table 21: Xience SBA Everolimus Eluting Coronary Stent System-A Prospective Multicenter Randomized Post Market All-comer Trial to Assess the Safety and Effectiveness of the Supraflex Sirolimus-eluting Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Table 22: Xience SBA Everolimus Eluting Coronary Stent System-Polish Bifurcation Optimal Treatment Strategy Study for Left Main Bifurcation Percutaneous Coronary Intervention (PCI)
Table 23: Adcomp Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Dual Drug Eluting Stent-Product Status
Table 25: Dual Drug Eluting Stent-Product Description
Table 26: Advanced Bifurcation Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Stenting System-Bare Metal Stent-Product Status
Table 28: Stenting System-Bare Metal Stent-Product Description
Table 29: Stenting System-Drug Eluting Stent-Product Status
Table 30: Stenting System-Drug Eluting Stent-Product Description
Table 31: Aeon Bioscience Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Drug Eluting Stent-Product Status
Table 33: Drug Eluting Stent-Product Description
Table 34: AlviMedica Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 35: BMS-Avantgarde-Product Status
Table 36: BMS-Avantgarde-Product Description
Table 37: Commander-Product Status
Table 38: Commander-Product Description
Table 39: Cre8 DES-Product Status
Table 40: Cre8 DES-Product Description
List of Figures
Figure 1: Coronary Stents-Pipeline Products by Stage of Development
Figure 2: Coronary Stents-Pipeline Products by Segment
Figure 3: Coronary Stents-Pipeline Products by Territory
Figure 4: Coronary Stents-Pipeline Products by Regulatory Path
Figure 5: Coronary Stents-Pipeline Products by Estimated Approval Date
Figure 6: Coronary Stents-Ongoing Clinical Trials
2 Introduction
2.1 Coronary Stents Overview
3 Products under Development
3.1 Coronary Stents-Pipeline Products by Stage of Development
3.2 Coronary Stents-Pipeline Products by Segment
3.3 Coronary Stents-Pipeline Products by Territory
3.4 Coronary Stents-Pipeline Products by Regulatory Path
3.5 Coronary Stents-Pipeline Products by Estimated Approval Date
3.6 Coronary Stents-Ongoing Clinical Trials
4 Coronary Stents-Pipeline Products under Development by Companies
4.1 Coronary Stents Companies-Pipeline Products by Stage of Development
4.2 Coronary Stents-Pipeline Products by Stage of Development
5 Coronary Stents Companies and Product Overview
6 Coronary Stents-Recent Developments
7 Appendix
List of Tables
Table 1: Coronary Stents-Pipeline Products by Stage of Development
Table 2: Coronary Stents-Pipeline Products by Segment
Table 3: Coronary Stents-Pipeline Products by Territory
Table 4: Coronary Stents-Pipeline Products by Regulatory Path
Table 5: Coronary Stents-Pipeline Products by Estimated Approval Date
Table 6: Coronary Stents-Ongoing Clinical Trials
Table 7: Coronary Stents Companies-Pipeline Products by Stage of Development
Table 8: Coronary Stents-Pipeline Products by Stage of Development
Table 9: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Second Generation Bioresorbable Vascular Scaffold-Product Status
Table 11: Second Generation Bioresorbable Vascular Scaffold-Product Description
Table 12: Xience SBA Everolimus Eluting Coronary Stent System-Product Status
Table 13: Xience SBA Everolimus Eluting Coronary Stent System-Product Description
Table 14: XIENCE Thin man DES-Product Status
Table 15: XIENCE Thin man DES-Product Description
Table 16: ZoMaxx Drug Eluting Coronary Stent System-Product Status
Table 17: ZoMaxx Drug Eluting Coronary Stent System-Product Description
Table 18: Abbott Vascular Inc-Ongoing Clinical Trials Overview
Table 19: Xience SBA Everolimus Eluting Coronary Stent System-A Multi-center, Randomized, Controlled Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries: CRYSTAL Study
Table 20: Xience SBA Everolimus Eluting Coronary Stent System-A Prospective Global Randomized Trial Assessing the Safety and Efficacy of the BuMA Supreme Biodegradable Drug Coated Coronary Stent System for Coronary Revascularization in Patients with Stable Coronary Artery Disease or Non-ST Segment Elevation Acute Coronary Syndromes
Table 21: Xience SBA Everolimus Eluting Coronary Stent System-A Prospective Multicenter Randomized Post Market All-comer Trial to Assess the Safety and Effectiveness of the Supraflex Sirolimus-eluting Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Table 22: Xience SBA Everolimus Eluting Coronary Stent System-Polish Bifurcation Optimal Treatment Strategy Study for Left Main Bifurcation Percutaneous Coronary Intervention (PCI)
Table 23: Adcomp Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Dual Drug Eluting Stent-Product Status
Table 25: Dual Drug Eluting Stent-Product Description
Table 26: Advanced Bifurcation Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Stenting System-Bare Metal Stent-Product Status
Table 28: Stenting System-Bare Metal Stent-Product Description
Table 29: Stenting System-Drug Eluting Stent-Product Status
Table 30: Stenting System-Drug Eluting Stent-Product Description
Table 31: Aeon Bioscience Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Drug Eluting Stent-Product Status
Table 33: Drug Eluting Stent-Product Description
Table 34: AlviMedica Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 35: BMS-Avantgarde-Product Status
Table 36: BMS-Avantgarde-Product Description
Table 37: Commander-Product Status
Table 38: Commander-Product Description
Table 39: Cre8 DES-Product Status
Table 40: Cre8 DES-Product Description
List of Figures
Figure 1: Coronary Stents-Pipeline Products by Stage of Development
Figure 2: Coronary Stents-Pipeline Products by Segment
Figure 3: Coronary Stents-Pipeline Products by Territory
Figure 4: Coronary Stents-Pipeline Products by Regulatory Path
Figure 5: Coronary Stents-Pipeline Products by Estimated Approval Date
Figure 6: Coronary Stents-Ongoing Clinical Trials
Note: Product cover images may vary from those shown
- Abbott Vascular Inc
- Adcomp Technologies Inc.
- Advanced Bifurcation Systems Inc
- Aeon Bioscience
- AlviMedica Medical Technologies Inc
- Amaranth Medical Inc
- Arterius Ltd
- Atrium Medical Corp
- Axordia Ltd (Inactive)
- B. Braun Melsungen AG
- Bactiguard Holding AB
- Bionext Biotech Products Ltd.
- Biosensors International Group Ltd
- Biosten, LLC
- Biotronik AG
- Biotronik SE & Co KG
- Boston Scientific Corp
- Cardionovum GmbH
- Cardiorev Pte Ltd (Inactive)
- Columbia University
- Concept Medical Inc
- Contego Medical LLC
- Cordis Corp
- Cytograft Tissue Engineering Inc (Inactive)
- DISA Vascular (Pty) Ltd
- Elixir Medical Corp
- Envision Scientific Pvt Ltd
- HangZhou HuaAn Biotechnology Co., Ltd.
- I.B.S. S.p.A.
- Icon Interventional Systems, Inc.
- ID Nest Medical SAS
- InspireMD Inc
- Japan Stent Technology Co., Ltd.
- JW Medical Systems Ltd
- Kaneka Corp
- Kyoto Medical Planning Co Ltd
- Liaoning Biomedical Materials R&D Center Co Ltd
- Lifetech Scientific (Shenzhen) Co Ltd
- MangoGen Pharma Inc
- Manli Cardiology Ltd
- Medinol Ltd
- Medlogics Device Corp (Inactive)
- Medtronic Plc
- Miami Cardiovascular Innovations
- Micell Technologies Inc
- Michigan Technological University
- MicroPort Scientific Corp
- Minvasys SAS
- MIV Therapeutics Inc
- NanoCoeur, Inc.
- Nanova, Inc
- National University of Ireland Galway
- Nesstent Ltd.
- Nexeon MedSystems Inc
- North Carolina State University
- Northwestern University
- NuVascular Technologies Inc
- OrbusNeich
- Palmaz Scientific Inc (Inactive)
- Pediastent LLC
- QualiMed Innovative Medizinprodukte GmbH
- Qvanteq AG
- Relisys Medical Devices Ltd
- REVA Medical Inc
- Rontis AG
- S3V Vascular Technologies
- Sahajanand Medical Technologies Pvt Ltd
- Shanghai Bio-heart Biological Technology Co Ltd
- Sino Medical Sciences Technology Inc
- Sree Chitra Tirunal Institute for Medical Sciences & Technology
- Stentys SA
- Svelte Medical Systems Inc
- Tepha Inc
- Terumo Corp
- TissueGen Inc
- TrendyMED Inc.
- University of Alabama at Birmingham
- University of Colorado
- University of Florida
- University of Michigan
- University of Strathclyde
- University of Utah
- VasoTech Inc.
- Viller Scientific LLC
- Vornia Biomaterials Ltd
- Xenogenics Corporation
Note: Product cover images may vary from those shown
